retatrutide safety profile Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide vs Tirzepatide: Which Weight-Loss
Description
Prescription GLP-1 receptor agonists - semaglutide, liraglutide, tirzepatide - are FDA-approved medications with extensive clinical trial evidence for efficacy in type 2 diabetes and chronic weight management

By answering a series of questions, youll learn more about why doctors prescribe GLP-1 medications and how they can help manage blood sugar

In studies, semaglutide was more effective at reducing body weight and HbA1c than placebo

This suggests that GLP-1 RAs may be particularly valuable for adolescents with genetic forms of obesity who have limited response to lifestyle interventions
PMID: 73 KanwalF
Nauck MA, Del Prato S, Duran-Garcia S, Rohwedder K, Langkilde AM, Sugg J, et al
